Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...

But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good ...

Moderna (NasdaqGS:MRNA) is shifting away from self-funding new Phase III vaccine trials in response to increased vaccine ...

Both the CEOs of Moderna and Pfizer said a booster dose of their respective COVID-19 vaccines could be required as soon as September for those who were among the earliest vaccinated. During an Axios ...

As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...

The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up. The Centers for Disease Control and ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual property developed by Monsanto, the crop science company the German company ...

WASHINGTON, D.C. — U.S. health officials announced Wednesday that booster shots will soon be available to Americans who have received the COVID-19 vaccines made by Pfizer and Moderna. Officials with ...

Stream Connecticut News for free, 24/7, wherever you are. The new vaccines, which target the omicron variant XBB.1.5, are approved for people 12 and older and are authorized under emergency use for ...

SAN FRANCISCO -- Herculean efforts by scientists and physicians around the world have resulted more than 50 experimental COVID-19 vaccines currently in global clinical trials. The focus in the U.S.

MOUNTAIN VIEW, Calif. -- It was the second shot California resident Veena Thomas had been for waiting for. Instead of relief what she felt was panic after the needle was pulled out. RELATED: Here's ...

Moderna’s 2028 cash breakeven guidance may not be feasible, analysts say.